Vista Oncology Inc PS

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma2 trials
• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Hodgkin lymphoma1 trial
• Lung cancer1 trial
• Myelodysplastic syndromes1 trial
• Myeloproliferative neoplasms1 trial
• Pancreatic cancer1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting2 trials
• Terminated2 trials
• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Incyte Corporation2 trials
• Amgen1 trial
• Celgene1 trial
• NovoCure Ltd.1 trial
• Seagen Inc.1 trial
• and 1 more

Running trials

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· Phase 3· Incyte Corporation· Source

• Recruiting

  A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  NCT05920356· Phase 3· Amgen· Source

• Active, not recruiting

  A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

  NCT04680052· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

  NCT03600441· Phase 2· Xynomic Pharmaceuticals, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Lung cancer1 recruiting

Closed trials

• Terminated

  Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

  NCT03646123· Phase 2· Seagen Inc.· Source

• Completed

  Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

  NCT03377491· Phase 3· NovoCure Ltd.· Source

• Terminated

  Connect® Myeloid Disease Registry

  NCT01688011· Celgene· Source